Verify regulatory 503A compliance and calculate out-of-pocket savings for compounded Tirzepatide & Semaglutide in Ohio compared to retail commercial list prices ($1050/mo).
Status: Available via State-Licensed Terminal Distributors
Ohio requires all compounding pharmacies dispensing to in-state residents to hold a Terminal Distributor of Dangerous Drugs (TDDD) license and comply with updated USP <797> sterile compounding protocols.
Statutory Citation: Ohio Admin. Code 4729:7-2 & State of Ohio Board of Pharmacy Rules
Ohio requires all compounding pharmacies dispensing to in-state residents to hold a Terminal Distributor of Dangerous Drugs (TDDD) license and comply with updated USP <797> sterile compounding protocols.
Yes, patients in Ohio can obtain compounded peptide formulations prescribed by a licensed healthcare provider and dispensed by an Ohio-licensed TDDD compounding pharmacy.
Browse deep clinical analysis and metabolic decision models on Groundwork.